Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veeru Kasivisvanathan

Showing results (1-10 of 200) with videos related to

Pageof 20
Sort By:
BJU International|September 9, 2020
Welcome to the September issue of Trainee's CornerVeeru Kasivisvanathan, Meghana Kulkarni
BJU International|October 7, 2020
Welcome to the October issue of Trainees' CornerVeeru Kasivisvanathan, Meghana Kulkarni
International Journal of Surgery (London, England)|December 15, 2015
Evidence based management of male lower urinary tract symptoms: A contemporary updateVeeru Kasivisvanathan, Mark Emberton
The Canadian Journal of Urology|June 15, 2018
Aquablation versus transurethral resection of the prostate: 1 year United States - cohort outcomesVeeru Kasivisvanathan, Muddassar Hussain
BJU International|August 11, 2020
Welcome to the trainees' corner!Veeru Kasivisvanathan, Meghana Kulkarni
European Urology|July 17, 2013
Reply from authors re: Hebert Alberto Vargas, Hedvig Hricak. Magnetic resonance imaging-targeted prostate biopsies: now is the time to START. Eur Urol 2013;64:553-4: START: the beginning of a multidisciplinary effort to define the role of MRI-targeted Biopsy in the detection of clinically significant prostate cancerCaroline M Moore, Veeru Kasivisvanathan,
International Journal of Surgery (London, England)|November 29, 2016
The diagnosis and management of small renal massesVeeru Kasivisvanathan, Nicholas Raison, Ben Challacombe
European Urology|March 12, 2022
Is It PRIME Time for Biparametric Magnetic Resonance Imaging in Prostate Cancer Diagnosis?Alexander Ng, Pramit Khetrapal, Veeru Kasivisvanathan
European Urology|April 20, 2021
Re: [<sup>177</sup>Lu]Lu-PSMA-617 Versus Cabazitaxel in Patients with Metastatic Castration-resistant Prostate Cancer (TheraP): A Randomised, Open-label, Phase 2 TrialSola Adeleke, Athar Haroon, Veeru Kasivisvanathan
Archivos Espanoles De Urologia|March 12, 2019
New standards in prostate biopsyJosé Marenco, Veeru Kasivisvanathan, Mark Emberton
Pageof 20

Showing results (1-10 of 200) with videos related to

Sort By:
Pageof 20
BJU International|September 9, 2020
Welcome to the September issue of Trainee's CornerVeeru Kasivisvanathan, Meghana Kulkarni
BJU International|October 7, 2020
Welcome to the October issue of Trainees' CornerVeeru Kasivisvanathan, Meghana Kulkarni
International Journal of Surgery (London, England)|December 15, 2015
Evidence based management of male lower urinary tract symptoms: A contemporary updateVeeru Kasivisvanathan, Mark Emberton
The Canadian Journal of Urology|June 15, 2018
Aquablation versus transurethral resection of the prostate: 1 year United States - cohort outcomesVeeru Kasivisvanathan, Muddassar Hussain
BJU International|August 11, 2020
Welcome to the trainees' corner!Veeru Kasivisvanathan, Meghana Kulkarni
European Urology|July 17, 2013
Reply from authors re: Hebert Alberto Vargas, Hedvig Hricak. Magnetic resonance imaging-targeted prostate biopsies: now is the time to START. Eur Urol 2013;64:553-4: START: the beginning of a multidisciplinary effort to define the role of MRI-targeted Biopsy in the detection of clinically significant prostate cancerCaroline M Moore, Veeru Kasivisvanathan,
International Journal of Surgery (London, England)|November 29, 2016
The diagnosis and management of small renal massesVeeru Kasivisvanathan, Nicholas Raison, Ben Challacombe
European Urology|March 12, 2022
Is It PRIME Time for Biparametric Magnetic Resonance Imaging in Prostate Cancer Diagnosis?Alexander Ng, Pramit Khetrapal, Veeru Kasivisvanathan
European Urology|April 20, 2021
Re: [<sup>177</sup>Lu]Lu-PSMA-617 Versus Cabazitaxel in Patients with Metastatic Castration-resistant Prostate Cancer (TheraP): A Randomised, Open-label, Phase 2 TrialSola Adeleke, Athar Haroon, Veeru Kasivisvanathan
Archivos Espanoles De Urologia|March 12, 2019
New standards in prostate biopsyJosé Marenco, Veeru Kasivisvanathan, Mark Emberton
Pageof 20